Cargando…
Prmt5 deficiency inhibits CD4+ T-cell Klf2/S1pr1 expression and ameliorates EAE disease
BACKGROUND: Protein arginine methyltransferase 5 (Prmt5) is the main type II methyltransferase, catalyzes protein arginine residue symmetric dimethylation, and modulates normal cellular physiology and disease progression. Prmt5 inhibition or deletion in CD4+ T cells has been reported to ameliorate e...
Autores principales: | Zheng, Yingxia, Chen, Zheyi, Zhou, Bingqian, Chen, Shiyu, Chen, Ningdai, Shen, Lisong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398933/ https://www.ncbi.nlm.nih.gov/pubmed/37533053 http://dx.doi.org/10.1186/s12974-023-02854-2 |
Ejemplares similares
-
PRMT5 Inhibition Promotes PD-L1 Expression and Immuno-Resistance in Lung Cancer
por: Hu, Rui, et al.
Publicado: (2022) -
Interleukin 32 Promotes Foxp3(+) Treg Cell Development and CD8(+) T Cell Function in Human Esophageal Squamous Cell Carcinoma Microenvironment
por: Han, Li, et al.
Publicado: (2021) -
PD-L1(+)CD8(+) T cells enrichment in lung cancer exerted regulatory function and tumor-promoting tolerance
por: Zheng, Yingxia, et al.
Publicado: (2022) -
Klf4 methylated by Prmt1 restrains the commitment of primitive endoderm
por: Zuo, Zhen-yu, et al.
Publicado: (2022) -
PRMT5 Promotes Cyclin E1 and Cell Cycle Progression in CD4 Th1 Cells and Correlates With EAE Severity
por: Amici, Stephanie A., et al.
Publicado: (2021)